Arcellx, Inc. (ACLX)
63.60
-1.53
(-2.35%)
USD |
NASDAQ |
Dec 30, 16:00
63.31
-0.29
(-0.46%)
After-Hours: 20:00
Arcellx Total Assets (Quarterly): 655.92M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 58.53B |
| Johnson & Johnson | 192.82B |
| Amicus Therapeutics, Inc. | 868.81M |
| Relmada Therapeutics, Inc. | 14.88M |
| Invivyd, Inc. | 139.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 215.14M |
| Shareholders Equity (Quarterly) | 440.78M |
| Debt to Equity Ratio | 0.1175 |
| Current Ratio | 3.987 |
| Net Debt Paydown Yield | 0.09% |